Barclays is proposing to slash the fixed pay it hands to its chief executive each year as part of an overhaul of his remuneration package that will see his maximum earnings capped at just over ...

Barclays PLC increased its stake in Structure Therapeutics Inc. (NASDAQ:GPCR – Free Report) by 64.5% in the 3rd quarter, HoldingsChannel reports.The institutional investor owned 81,138 shares of ...

This move is part of its ongoing strategy to optimize its capital structure and enhance shareholder value. The buy-back program, which commenced on August 5, 2024, has seen Barclays acquire over ...